Siloton, a Bristol, UK-based health technology startup, raised £860K in Seed funding.
Backers included Evenlode Foundation alongside members of the Southeast Angels, the Francis Crick Institute, and other experienced angel investors. They were complemented by non-dilutive funding from an Innovate UK Biomedical Catalyst grant, taking total funding in the company to date to £1.7m.
The company intends to use the funds to further develop its Akepa optical coherence tomography (OCT) chip technology and bring a version of the device for researchers to market in 2025.
Led by Alasdair B. Pricem Siloton is a diagnosis and monitoring company focused on improving the way people with eye disease receive sight-saving eye scans wherever and whenever they need it. Its photonic chip technology aims to transform clinical-grade medical imaging systems into devices that can be accessed anywhere. They are supported by a number of players in the ophthalmology space, including Moorfields Eye Hospital and the Macular Society.
Customers include the European Space Agency, who need a long-term solution to monitoring eye problems that astronauts frequently develop while in space.
Customers include the European Space Agency, who need a long-term solution to monitoring eye problems that astronauts frequently develop while in space.
FinSMEs
21/10/2024